Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0243
+0.0043 (21.50%)
Sep 24, 2026, 3:59 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $11.63 million as of September 25, 2026. Its market cap has decreased by -61.61% in one year.
Market Cap
11.63M
Enterprise Value
24.22M
Revenue
250.00K
Ranking
n/a
PE Ratio
0.05
Stock Price
$0.02
ChartMarket Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 11.63M, an increase of 27.20%. That is a compound annual growth rate of 3.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 11.63M | -68.68% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 17.38M |
| Finch Therapeutics Group | 16.62M |
| ZIVO Bioscience | 14.95M |
| Synlogic | 13.96M |
| Anebulo Pharmaceuticals | 13.26M |
| Nymox Pharmaceutical | 10.50M |
| Brainstorm Cell Therapeutics | 10.48M |
| Zeo ScientifiX | 9.83M |